Nashville, TN, United States of America

Alexa E Richardson

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Vanderbilt University. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexa E Richardson. Retrieved from https://idiyas.com/inventor/alexa-e-richardson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Alexa E Richardson

Introduction

Alexa E Richardson is an accomplished inventor based in Nashville, TN (US). She has made significant contributions to the field of neuroscience through her innovative work. With a total of 2 patents to her name, Richardson is recognized for her research and development in the area of muscarinic acetylcholine receptors.

Latest Patents

Richardson's latest patents focus on positive modulators of the muscarinic acetylcholine receptor M4. These include deuterium-labeled compounds that may have therapeutic applications in treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction. Her work on these positive allosteric modulators highlights the potential for advancements in medical treatments.

Career Highlights

Richardson is affiliated with Vanderbilt University, where she continues her research and development efforts. Her academic background and ongoing projects contribute to the advancement of knowledge in her field.

Collaborations

Some of her notable coworkers include Darren W Engers and Kayla J Temple, who collaborate with her on various research initiatives.

Conclusion

Alexa E Richardson's innovative work in the field of neuroscience demonstrates her commitment to advancing medical science. Her patents and research have the potential to impact the treatment of significant health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…